Last update 20 Mar 2025

BMS-813160

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Action
antagonists
Mechanism
CCR2 antagonists(C-C chemokine receptor type 2 antagonists), CCR5 antagonists(C-C chemokine receptor type 5 antagonists)
Originator Organization
Active Organization
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC25H40N8O2
InChIKeyCMVHFGNTABZQJU-HCXYKTFWSA-N
CAS Registry1286279-29-5

External Link

KEGGWikiATCDrug Bank
---

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced cancerPhase 2
Australia
02 Feb 2017
Advanced cancerPhase 2
Canada
02 Feb 2017
Diabetes Mellitus, Type 2Phase 2
France
18 Mar 2013
Diabetes Mellitus, Type 2Phase 2
United States
18 Mar 2013
Diabetes Mellitus, Type 2Phase 2
Denmark
18 Mar 2013
Diabetes Mellitus, Type 2Phase 2
Canada
18 Mar 2013
Diabetic NephropathiesPhase 2
France
18 Mar 2013
Diabetic NephropathiesPhase 2
Canada
18 Mar 2013
Diabetic NephropathiesPhase 2
Denmark
18 Mar 2013
Diabetic NephropathiesPhase 2
United States
18 Mar 2013
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
13
(rleveywudu) = gtpriysyvw hknoerbvmi (hgyrtfqvsc )
Positive
24 Jan 2023
Phase 1/2
40
(Part A - Experimental Dose Level 0)
outgirctom(undhgbvwpc) = berheqjqlc ojhgwmwltw (ufuukckwbp, qkajlrunow - pkuexaoxzh)
-
30 Nov 2022
Peripheral blood+nab-paclitaxel+Gemcitabine
(Part A - Control (Chemotherapy Only))
shrlzwnlrk(ebhvsmfbdh) = aptxfghydu wwqmnldrkc (cbsnsxtkrb, pmwftavzgr - fcdlgvtmvd)
Phase 2
319
(BMS-813160 150 mg QD)
kxyvuaptlw(cidbfrumie) = gpselrpvva ujdntpaite (ytbdgdgryv, fpccvcxzyl - nuikheuxgg)
-
25 Jun 2019
(BMS-813160 300 mg BID)
kxyvuaptlw(cidbfrumie) = sggipliciw ujdntpaite (ytbdgdgryv, rmlhtupsbd - ulyeqlkaad)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free